[Effect of 2 phenyl-5-7 dioxyacetate of sodium benzo- -pyrone on various hemorrhagic manifestations of diabetic microangiopathy. Preliminary note].
D000085:Acetates / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D002198:Capillary Fragility / Q000187:drug effects; D002200:Capillary Resistance / Q000187:drug effects; D003925:Diabetic Angiopathies / Q000150:complications* / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D005260:Female; D005419:Flavonoids / Q000627:therapeutic use*; D006417:Hematuria / Q000188:drug therapy; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D007677:Kidney Function Tests; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D012166:Retinal Hemorrhage / Q000188:drug therapy
D000085:Acetates; D005419:Flavonoids
Azione del 2 fenil-5-7 diossiacetato di sodio benzo- -pirone su talune manifestazioni emorragiche della microangiopatia diabetica. Nota preliminare.